A systematic analysis of the literature on the post-COVID-19 condition in Latin America focusing on epidemiology, clinical characteristics, and risk of bias
Medwave,
Journal Year:
2025,
Volume and Issue:
25(01), P. e3014 - e3014
Published: Jan. 16, 2025
This
analysis
article
aimed
to
identify
and
analyze
all
articles
published
on
the
post-COVID-19
condition
in
Latin
America
Caribbean,
focusing
epidemiology,
clinical
characteristics,
risk
of
bias.
We
did
a
systematic
survey
literature
with
broad
inclusion
criteria.
The
only
exclusion
criteria
were
referring
post-acute
COVID-19
sequelae
after
an
intensive
care
unit
stay,
which
we
distinguish
from
condition.
searched
MEDLINE/PubMed,
LILACS,
SciELO,
Scopus,
Web
Science,
Epistemonikos.
included
55
records,
48
original
(44
observational
research,
29
had
comparison
group;
four
reviews).
Various
definitions
for
long
COVID
reported,
or
none,
few
used
World
Health
Organization
None
studies
reported
prevalence
rates
region.
extracted
signs
symptoms
our
Using
Johanna
Briggs
Institute
critical
appraisal
tools
analytic
found
that
most
prone
limitations
biases.
conclude
more
research
should
be
done
using
rigorous
study
designs
inform
public
health
strategies.
Language: Английский
Sociodemographic and health-related predictors of COVID-19 booster uptake among fully vaccinated adults
Vaccine,
Journal Year:
2025,
Volume and Issue:
54, P. 127048 - 127048
Published: March 30, 2025
Language: Английский
Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach
Open Forum Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
11(9)
Published: Aug. 27, 2024
Abstract
While
the
acute
manifestations
of
infectious
diseases
are
well
known,
in
some
individuals,
symptoms
can
either
persist
or
appear
after
period.
Postviral
fatigue
syndromes
recognized
with
other
viral
infections
and
described
coronavirus
disease
2019
(COVID-19).
We
have
a
growing
number
individuals
that
for
weeks,
months,
years.
Here,
we
share
evidence
regarding
abnormalities
associated
postacute
sequelae
COVID-19
(PASC)
therapeutics.
describe
physiological
biochemical
seen
reporting
PASC.
several
evidence-based
interventions
to
offer
patients.
It
is
expected
this
understanding
mechanisms
driving
PASC
benefits
certain
therapeutics
may
not
only
lead
better
outcomes
those
but
also
potential
treating
postinfectious
sequelae.
Language: Английский
Impact of the COVID-19 infection on children with allergic diseases in China
Pediatric Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 27, 2024
Language: Английский
Prevalence of COVID‐19 and Long COVID by industry and occupation: Behavioral Risk Factor Surveillance System 2022
American Journal of Industrial Medicine,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 11, 2024
Abstract
Background
Workers
in
healthcare
and
other
essential
occupations
had
elevated
risks
for
COVID‐19
infection
early
the
pandemic.
No
survey
of
U.S.
workers
to
date
has
comprehensively
assessed
prevalence
both
Long
COVID
across
industries
(I&O)
at
a
detailed
level.
Methods
Behavioral
Risk
Factor
Surveillance
System
data
2022
from
39
states,
Guam,
Virgin
Islands
were
used
estimate
self‐reported
history
COVID,
as
well
among
those
reporting
prior
COVID‐19,
by
broad
I&O.
Adjusted
ratios
compare
outcome
each
I&O
all
combined.
Results
By
I&O,
healthcare,
protective
services,
education
prevalences
COVID‐19.
The
was
service
but
not
workers.
Detailed
with
significantly
included
Dairy
Product
Manufacturing
industry
subsets
mining
Both
bartenders/drinking
places
personal
care
appearance
farmworkers
who
reported
having
Conclusions
Industries
levels
or
this
study
may
warrant
increased
measures
prevent
transmission
airborne
respiratory
viruses.
Accommodations
are
key
component
supporting
workplaces.
This
new
information
about
distribution
suggests
where
employer
understanding
implementation
tailored
workplace
supports
accommodations
most
needed
support
continued
employment
affected
Language: Английский
Functional disabilities and adverse well‐being by COVID‐19 and Long COVID history and employment status: 2022 Behavioral Risk Factor Surveillance System
American Journal of Industrial Medicine,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 25, 2024
Abstract
Background
Long
COVID
can
lead
to
functional
disabilities
and
decreased
well‐being
limit
the
ability
work.
No
study
has
yet
assessed
associations
of
SARS‐CoV‐2‐infection
with
specific
measures
among
workers
by
employment
status.
Methods
Using
data
from
U.S.
Behavioral
Risk
Factor
Surveillance
System,
we
prevalence
adults
prime
working
age
(25–54
years)
status
self‐reported
COVID‐19
history.
Within
each
status,
generated
adjusted
ratios
(aPRs)
comparing
respondents
2022
COVID‐19/Long
category
in
that
before
pandemic
(2019).
Results
In
2022,
prevalences
disability
except
vision
all
adverse
were
highest
9.2%
reporting
a
history
COVID.
For
outcome,
lowest
for
those
unable
cognitive
(16.4%
employees,
21.4%
self‐employed)
depression
(31.2%
36.4%,
respectively)
more
than
double
2019
levels.
Increases
lower
but
statistically
significant
not
Conclusions
The
high
have
implications
employers.
Also
concerning
are
smaller
increases
COVID,
given
large
number
affected
workers.
Mitigating
effects
on
will
involve
efforts
multiple
domains:
reducing
incidence,
increasing
healthcare
practitioner
awareness,
improving
diagnosis
treatments,
employer
awareness
best
practices
accommodating
Language: Английский